Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
CodeAllP: Open-market purchaseS: Open-market saleA: Grant or awardM: Option exerciseF: Tax withholdingG: GiftD: Disposition to issuerC: ConversionX: In-the-money exerciseJ: Other
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Dec 30, 2024 | DDS DILLARD'S, INC. | DILLARD ALEX PRESIDENT | AGrant or award Common Class A | +25 | $445.40 | $11k | 1,017,317 | Dec 31, 2024 |
| Dec 30, 2024 | DDS DILLARD'S, INC. | MATHENY DRUE EXECUTIVE VICE PRESIDENT | AGrant or award Common Class A | +18 | $445.40 | $8,017 | 403,365 | Dec 31, 2024 |
| Dec 30, 2024 | DDS DILLARD'S, INC. | BOLIN TOM W VICE PRESIDENT | AGrant or award Common Class A | +17 | $445.40 | $7,572 | 1,396 | Dec 31, 2024 |
| Dec 27, 2024 | IVR Invesco Mortgage Capital Inc. | Day John director | JOther 7.75 % Series B Preferred Stock | -5,300 | $25.00 | $133k | 0 | Dec 31, 2024 |
| Dec 27, 2024 | GSAT Globalstar, Inc. | Clary Rebecca VP & Chief Financial Officer | AGrant or award Voting Common Stock | +81,395 | $0.00 | $0 | 1,477,422 | Dec 31, 2024 |
| Dec 30, 2024 | WDAY Workday, Inc. | DUFFIELD DAVID A owner | SOpen-market sale Class A Common Stockindirect: Dave and Cheryl Duffield Foundation10b5-1 | -7,711 | $259.95 | $2.0M | 220,289 | Dec 31, 2024 |
| Dec 30, 2024 | WDAY Workday, Inc. | DUFFIELD DAVID A owner | SOpen-market sale Class A Common Stockindirect: Dave and Cheryl Duffield Foundation10b5-1 | -7,773 | $260.93 | $2.0M | 212,516 | Dec 31, 2024 |
| Dec 30, 2024 | WDAY Workday, Inc. | DUFFIELD DAVID A owner | SOpen-market sale Class A Common Stockindirect: Dave and Cheryl Duffield Foundation10b5-1 | -25,466 | $261.99 | $6.7M | 187,050 | Dec 31, 2024 |
| Dec 30, 2024 | WDAY Workday, Inc. | DUFFIELD DAVID A owner | SOpen-market sale Class A Common Stockindirect: Dave and Cheryl Duffield Foundation10b5-1 | -14,424 | $262.61 | $3.8M | 172,626 | Dec 31, 2024 |
| Dec 30, 2024 | WDAY Workday, Inc. | DUFFIELD DAVID A owner | SOpen-market sale Class A Common Stockindirect: Dave and Cheryl Duffield Foundation10b5-1 | -626 | $264.12 | $165k | 172,000 | Dec 31, 2024 |
| Dec 23, 2024 | AZO AUTOZONE INC | RAUCH LUCAS J. SVP, Merchandising & Sourcing | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +1,500 | $0.00 | $0 | 1,500 | Dec 31, 2024 |
| Dec 27, 2024 | BSLK Bolt Projects Holdings, Inc. | Golden Arrow Sponsor, LLC owner | SOpen-market sale Common Stock | -221,144 | $0.50 | $112k | 9,441,558 | Dec 31, 2024 |
| Dec 30, 2024 | BSLK Bolt Projects Holdings, Inc. | Golden Arrow Sponsor, LLC owner | SOpen-market sale Common Stock | -278,856 | $0.51 | $142k | 9,162,702 | Dec 31, 2024 |
| Dec 31, 2024 | XPO XPO, Inc. | BRADLEY S JACOBS Executive Chairman | MOption exercise Common Stock | +1,174,495 | $0.00 | $0 | 1,589,983 | Dec 31, 2024 |
| Dec 31, 2024 | XPO XPO, Inc. | BRADLEY S JACOBS Executive Chairman | FTax withholding Common Stock | -544,261 | $131.15 | $71M | 1,045,722 | Dec 31, 2024 |
| Dec 31, 2024 | XPO XPO, Inc. | BRADLEY S JACOBS Executive Chairman | MOption exercise Restricted Stock Unitderivative | -1,174,495 | $0.00 | $0 | 0 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Tierney David S director | MOption exercise Common Stock, par value $0.001 per share | +1,333 | - | - | 351,620 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Tierney David S director | MOption exercise Restricted Stock Unitsderivative | -1,333 | $0.00 | $0 | 212,274 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Sundaram Preethi Chief Strategy Officer | MOption exercise Common Stock, par value $0.001 per share | +6,667 | - | - | 36,648 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Sundaram Preethi Chief Strategy Officer | FTax withholding Common Stock, par value $0.001 per share | -2,345 | - | - | 34,303 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Sundaram Preethi Chief Strategy Officer | MOption exercise Restricted Stock Unitsderivative | -6,667 | $0.00 | $0 | 695,099 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | O'Keeffe Charles B director | MOption exercise Common Stock, par value $0.001 per share | +1,333 | - | - | 728,470 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | O'Keeffe Charles B director | MOption exercise Restricted Stock Unitsderivative | -1,333 | $0.00 | $0 | 212,274 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Miller Steve Chief Op. & Scientific Officer | MOption exercise Common stock, par value $0.001 per share | +14,000 | - | - | 935,996 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Miller Steve Chief Op. & Scientific Officer | MOption exercise Restricted Stock Unitsderivative | -14,000 | $0.00 | $0 | 1,538,176 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | INGENITO GARY Chief Med. & Reg. Officer | MOption exercise Common Stock, par value $0.001 per share | +9,000 | - | - | 64,849 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | INGENITO GARY Chief Med. & Reg. Officer | FTax withholding Common Stock, par value $0.001 per share | -3,541 | - | - | 61,308 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | INGENITO GARY Chief Med. & Reg. Officer | MOption exercise Restricted Stock Unitsderivative | -9,000 | $0.00 | $0 | 1,025,282 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Harper Molly director | MOption exercise Common Stock, par value $0.001 per share | +1,333 | - | - | 2,746 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Harper Molly director | MOption exercise Restricted Stock Unitsderivative | -1,333 | $0.00 | $0 | 131,274 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Elsbernd Brian Chief Compliance/Legal Officer | MOption exercise Common Stock, par value $0.001 per share | +6,667 | - | - | 183,191 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Elsbernd Brian Chief Compliance/Legal Officer | FTax withholding Common Stock, par value $0.001 per share | -1,941 | - | - | 181,250 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Elsbernd Brian Chief Compliance/Legal Officer | MOption exercise Restricted Stock Unitsderivative | -6,667 | $0.00 | $0 | 1,081,276 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | DENKHAUS DONALD A director | MOption exercise Common Stock, par value $0.001 per share | +1,333 | - | - | 441,079 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | DENKHAUS DONALD A director | MOption exercise Restricted Stock Unitsderivative | -1,333 | $0.00 | $0 | 212,274 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Del Carmen Jeffrey Chief Commercial Officer | MOption exercise Common stock, par value $0.001 per share | +8,667 | - | - | 26,720 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Del Carmen Jeffrey Chief Commercial Officer | FTax withholding Common stock, par value $0.001 per share | -3,839 | - | - | 22,881 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Del Carmen Jeffrey Chief Commercial Officer | MOption exercise Restricted Stock Unitsderivative | -8,667 | $0.00 | $0 | 941,675 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Daly Richard J President and CEO | MOption exercise Common Stock, par value $0.001 per share | +1,333 | - | - | 236,157 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Daly Richard J President and CEO | FTax withholding Common Stock, par value $0.001 per share | -324 | - | - | 235,833 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Daly Richard J President and CEO | MOption exercise Restricted Stock Unitsderivative | -1,333 | $0.00 | $0 | 2,280,858 | Dec 31, 2024 |
| Dec 30, 2024 | DAY Dayforce, Inc. | HAGERTY THOMAS M director | GGift Common Stock | -14,000 | - | - | 76,745 | Dec 31, 2024 |
| Dec 31, 2024 | CSGS CSG SYSTEMS INTERNATIONAL INC | Shepherd Brian A. President & CEO | DDisposition to issuer Common Stock | -42,135 | $0.00 | $0 | 540,194 | Dec 31, 2024 |
| Dec 27, 2024 | VFC V F CORP | CHO ALEX director | AGrant or award Phantom Stockderivative | +1,148 | $21.77 | $25k | 13,205 | Dec 31, 2024 |
| Dec 27, 2024 | VFC V F CORP | Carucci Richard director | AGrant or award Phantom Stock-dderivative | +3,445 | $21.77 | $75k | 68,316 | Dec 31, 2024 |
| Dec 30, 2024 | OVBC OHIO VALLEY BANC CORP | EASTMAN BRENT R director | JOther Common Shares | +2,754 | $24.23 | $67k | 79,666 | Dec 31, 2024 |
| Dec 30, 2024 | OVBC OHIO VALLEY BANC CORP | CANADY KIMBERLY A director | JOther Common Sharesindirect: Spouse C/F Son (REC) | +0 | $24.23 | $4 | 4 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | Marissa Solis Michel director | DDisposition to issuer Common Stock, par value $0.01 per share | -87,658 | $4.70 | $412k | 0 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | GERKE THOMAS A director | DDisposition to issuer Common Stock, par value $0.01 per share | -173,679 | $4.70 | $816k | 0 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | Rahe Maribeth S director | DDisposition to issuer Common Stock, par value $0.01 per share | -203,319 | $4.70 | $956k | 0 | Dec 31, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.